Liu et al. (2015) demonstrated a decreasing trend in SMAD4 protein levels from histological grade I to III, suggesting that SMAD4 may participate in the carcinogenesis and progression of breast ductal carcinoma. This evidence concerns the gene SMAD4 and breast ductal adenocarcinoma.